Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
Therapeutic Advances in Hematology|April 24, 2013
Using biologic predictive factors to direct therapy of diffuse large B-cell lymphomaKieron Dunleavy, Cliona Grant, Wyndham H WilsonCurrent Opinion in Hematology|November 25, 2010
Neutropenia associated with rituximab therapyCliona Grant, Wyndham H Wilson, Kieron DunleavyOncology (Williston Park, N.Y.)|May 21, 2014
Appropriate management of molecular subtypes of diffuse large B-cell lymphomaKieron Dunleavy, Wyndham H WilsonBlood|December 16, 2014
Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?Kieron Dunleavy, Wyndham H WilsonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2011
Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphomaKieron Dunleavy, Wyndham H WilsonCurrent Hematologic Malignancy Reports|May 19, 2011
Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?Cliona Grant, Kieron Dunleavy, Franziska C Eberle, et al.Current Hematologic Malignancy Reports|July 27, 2012
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?Kieron Dunleavy, Cliona Grant, Franziska C Eberle, et al.Current Hematologic Malignancy Reports|July 21, 2012
Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processesKieron Dunleavy, Mark Roschewski, Wyndham H WilsonSeminars in Hematology|March 31, 2010
Rituximab-associated neutropeniaKieron Dunleavy, Kevin Tay, Wyndham H WilsonPageof 23